Bellicum Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | $1.57 | $1.57 | $1.57 |
| Q2 2024 | 0 | $1.34 | $1.34 | $1.34 |
| Q3 2024 | 0 | $1.54 | $1.54 | $1.54 |
Bellicum Pharmaceuticals, Inc. Earnings Date And Information
Bellicum Pharmaceuticals, Inc. last posted its earnings results on Thursday, August 10th, 2023. The company reported $-0.24 earnings per share for the quarter, topping analysts' consensus estimates of $-0.29 by $0.05. The company had revenue of 1.00 M for the quarter and had revenue of 1.50 M for the year. Bellicum Pharmaceuticals, Inc. has generated $-1 earnings per share over the last year ($-0.81 diluted earnings per share) and currently has a price-to-earnings ratio of -0.28. Bellicum Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 29th, 2024 based on prior year's report dates.
Bellicum Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2023 | Q3 2023 | -$0.02 | $0 | $1.00 M | ||
| 08/10/2023 | Q2 2023 | -$0.29 | -$0.24 | 0.05 | $0 | $0 |
| 05/11/2023 | Q1 2023 | -$0.34 | -$0.24 | 0.1 | $8,000 | |
| 03/31/2023 | Q4 2022 | -$0.93 | -$1.08 | -0.15 | $500,000 | |
| 11/10/2022 | Q3 2022 | -$0.64 | -$0.24 | 0.4 | $68.12 M | $1.00 M |
| 08/11/2022 | Q2 2022 | -$0.69 | -$0.05 | 0.64 | $1.37 M | $0 |
| 05/12/2022 | Q1 2022 | -$0.67 | -$0.30 | 0.37 | $0 | |
| 03/24/2022 | Q4 2021 | -$0.40 | $0.12 | 0.52 | $500,000 | |
| 11/04/2021 | Q3 2021 | $0.08 | $250,000 | $5.00 M | ||
| 08/12/2021 | Q2 2021 | -$1.37 | -$0.22 | 1.15 | $250,000 | $700,000 |
| 05/14/2021 | Q1 2021 | -$1.12 | $0 | |||
| 03/30/2021 | Q4 2020 | $0.99 | $500,000 | |||
| 11/05/2020 | Q3 2020 | -$3.29 | -$0.18 | 3.11 | $72.85 M | $0 |
| 08/06/2020 | Q2 2020 | -$3.33 | -$8.55 | -5.22 | $1.46 M | $0 |
| 05/07/2020 | Q1 2020 | -$2.73 | $1.09 | 3.82 | $0 | |
| 03/12/2020 | Q4 2019 | -$4.90 | -$5.82 | -0.92 | $5.13 M | |
| 11/06/2019 | Q3 2019 | -$5.70 | -$6.79 | -1.09 | $80,279 | $103,000 |
| 08/05/2019 | Q2 2019 | -$5.40 | -$5.85 | -0.45 | $1.30 M | $1.39 M |
| 05/07/2019 | Q1 2019 | -$5.60 | -$5.54 | 0.06 | $516,000 | |
| 03/12/2019 | Q4 2018 | -$5.90 | -$6.27 | -0.37 | $312,000 |
Bellicum Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is Bellicum Pharmaceuticals, Inc.'s earnings date?
Bellicum Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Friday, March 29th, 2024 based off last year's report dates.
-
Did Bellicum Pharmaceuticals, Inc. beat their earnings estimates last quarter?
In the previous quarter, Bellicum Pharmaceuticals, Inc. (:BLCM) reported $-0.24 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.29 by $0.05.
-
How can I listen to Bellicum Pharmaceuticals, Inc.'s earnings conference call?
The conference call for Bellicum Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read Bellicum Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for Bellicum Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much revenue does Bellicum Pharmaceuticals, Inc. generate each year?
Bellicum Pharmaceuticals, Inc. (:BLCM) has a recorded annual revenue of $1.50 M.
-
How much profit does Bellicum Pharmaceuticals, Inc. generate each year?
Bellicum Pharmaceuticals, Inc. (:BLCM) has a recorded net income of $1.50 M. Bellicum Pharmaceuticals, Inc. has generated $-0.81 earnings per share over the last four quarters.
-
What is Bellicum Pharmaceuticals, Inc.'s price-to-earnings ratio?
Bellicum Pharmaceuticals, Inc. (:BLCM) has a price-to-earnings ratio of -0.28 and price/earnings-to-growth ratio is -0.02.
